04.09.2019 - US pharma Zogenix has agreed to buy Modis Therapeutics, a privately held biopharmaceutical company focused on developing novel therapies for rare genetic diseases with high unmet...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)